174 related articles for article (PubMed ID: 18245130)
1. The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND.
Huddart RA
Ann Oncol; 2008 Feb; 19(2):203-4. PubMed ID: 18245130
[No Abstract] [Full Text] [Related]
2. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
[No Abstract] [Full Text] [Related]
3. Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.
Masterson TA; Shayegan B; Carver BS; Bajorin DF; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2012 Jan; 79(1):156-9. PubMed ID: 22202548
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract][Full Text] [Related]
5. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
Heidenreich A; Paffenholz P; Nestler T; Pfister D
Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
[TBL] [Abstract][Full Text] [Related]
6. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
[TBL] [Abstract][Full Text] [Related]
8. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
10. Management of Stage I Nonseminomatous Germ Cell Tumors.
Kovac E; Stephenson AJ
Urol Clin North Am; 2015 Aug; 42(3):299-310. PubMed ID: 26216817
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
[TBL] [Abstract][Full Text] [Related]
13. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted laparoscopic retroperitoneal lymph node dissection for stage IIIb mixed germ cell testicular cancer after chemotherapy.
Lee SH; Kim DS; Chang SG; Jeon SH
Korean J Urol; 2015 Jul; 56(7):540-4. PubMed ID: 26175874
[TBL] [Abstract][Full Text] [Related]
15. The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors.
Carver BS; Sheinfeld J
Nat Clin Pract Urol; 2005 Jul; 2(7):330-5. PubMed ID: 16474785
[TBL] [Abstract][Full Text] [Related]
16. Controversies in the management of stage 1 non-seminomatous germ cell tumors.
Coleman S; Stephenson A
Curr Urol Rep; 2013 Oct; 14(5):506-10. PubMed ID: 23901036
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence.
Nicolai N; Miceli R; Necchi A; Biasoni D; Catanzaro M; Milani A; Piva L; Pizzocaro G; Stagni S; Torelli T; Salvioni R
Eur Urol; 2010 Dec; 58(6):912-8. PubMed ID: 20817343
[TBL] [Abstract][Full Text] [Related]
18. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
Feldman DR
Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
[No Abstract] [Full Text] [Related]
19. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
[TBL] [Abstract][Full Text] [Related]
20. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]